| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e673458c8c443e6fcd34bbc9565bf7f7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 |
| filingDate |
2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf966e95610d1b88f81aac455c419866 |
| publicationDate |
2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CY-1109615-T1 |
| titleOfInvention |
Cephalosporin in crystalline form |
| abstract |
The present invention relates to cephalosporin of formula I in crystalline form. The compound of formula I in crystalline form is useful as antibiotics having strong and broad antibacterial activity, especially against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (Pseudo-monas aeruginosa). |
| priorityDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |